Registe-se para criar alertas sobre instrumentos,
eventos económicos e conteúdo por autores seguidos
Registo gratuito Já tem uma conta? Iniciar sessão
Cotações
Todos os tipos
- Todos os tipos
- Índices
- Ações
- ETFs
- Fundos
- Matérias-primas
- Moedas
- Criptomoedas
- Obrigações
- Certificados
Por favor, tente outra pesquisa
🤑 Uma oportunidade única. Aproveite esta oferta de um desconto de 60% na Black Friday antes que desapareça...
OBTER OFERTA
Allianz Biotechnologie A Eur (0P00000CML)
Adicionar/Remover de uma carteira
Adicionar à watchlist
216,460
+1,890
+0,88%
26/11 - Atraso dados. Moeda em EUR
Tipo:
Fundo
Mercado:
Alemanha
Emissor:
Allianz Global Investors GmbH
ISIN:
DE0008481862
Classe de Ativo:
Açao
- Classificação da Morningstar:
- Ativos Totais: 284,15M
Allianz Biotechnologie A EUR
216,460
+1,890
+0,88%
Allianz Biotechnologie A Eur - Vista Geral
Nesta página encontrará um perfil aprofundado de Allianz Biotechnologie A Eur. Fique a saber mais sobre as pessoas-chave, o total de ativos, a estratégia de investimento e a informação de contacto de 0P00000CML, e mais.
Informações de Contacto
Endereço
L-2633 Senningerberg
Frankfurt am Main, 60323
Germany
Frankfurt am Main, 60323
Germany
Telefone
+49 (0) 69 2443-1140
Fax
Milano
Principais Executivos
| Nome | Título | Desde | Até |
|---|---|---|---|
| Christopher Chin | - | 2018 | Agora |
| Peter Pirsch | Senior Portfolio Manager | 2019 | 2023 |
| Biografia | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| Kimberlee W. Millar | Vice President | 2018 | 2021 |
| Biografia | Ms. Millar is a portfolio manager, analyst and director with Allianz Global Investors, which she joined in 2005. As a generalist for the Disciplined Equities group, her primary responsibility is conducting company research; she also helps improve the group’s overall investment processes and contributes toward its portfolio-management efforts. Ms. Millar has 23 years of investment industry experience. She previously worked as an assistant economist at the Investment Company Institute in Washington, D.C., producing mutual-fund-industry research for investment-management firms’ research and marketing departments. Before that, Ms. Millar worked at Heiden Associates Inc., an economic consulting firm in Washington, D.C. She has a B.A. in economics from the University of Calgary, Canada, and an M.A. in economics from Queen’s University, Canada. Ms. Millar is a CFA charterholder and a member of the CFA Institute. | ||
| Hugo Ong | - | 2018 | 2021 |
| Peter Pirsch | Senior Portfolio Manager | 2018 | 2019 |
| Biografia | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| John R. Schroer | Portfolio Manager | 2014 | 2018 |
| Biografia | Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. He is the sector head of the Health Care team. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. in history and international relations and an M.B.A. in finance from the University of Wisconsin. | ||
| Paul A. Wagner | Senior Research Analyst | 2012 | 2014 |
| Biografia | Mr. Wagner, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 2006. He has biotechnology responsibilities for the US Health Care team and has 14 years of investment-industry experience. Mr. Wagner previously worked at PDL BioPharma in corporate and business development, and was a vice president and senior equity-research analyst in the biotechnology sector at Lehman Brothers. He has a B.S. in chemistry from the University of Wisconsin and a Ph.D. in chemistry from the California Institute of Technology. | ||
| Nicole Papassavvas | - | 2008 | 2012 |
| Javier Latorre | - | 2007 | 2012 |
Escreva o que você pensa sobre Allianz Biotechnologie A Eur
Tem certeza que deseja eliminar este gráfico?
Eliminar Cancelar
Substituir o gráfico anexado por um novo gráfico?
Substituir Cancelar
Diretrizes para Comentários
Anexar um gráfico a um comentário
Confirmar Bloqueio
Quer mesmo bloquear %USER_NAME%?
Se o fizer, não poderá consultar as mensagens de %USER_NAME% e vice versa em Investing.com.
Adicionou %USER_NAME% com sucesso à sua Lista de Bloqueios
Uma vez que acabou de desbloquear esta pessoa, deve aguardar 48 horas antes de bloqueá-la novamente.
Denunciar este comentário
Diga-nos o que achou deste comentário
Comentário denunciado
Obrigado!
Seu comentário foi enviado aos moderadores para revisão